跳至主要内容
临床试验/RBR-2rcm2g
RBR-2rcm2g招募中2 期

Safety and efficacy of different regimens of Primaquine on Vivax Malaria treatment in Glucose-6-phospate Dehydrogenase Deficient patients admitted at the Fundação De Medicina Tropical Doutor Heitor Vieira Dourado, Manaus, Amazonas

Fundação de Medicina Tropical Heitor Vieira Dourado - FMTHVD0 个研究点开始时间: 2018年2月7日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

年龄范围
6M 至 80Y(—)

入选标准

  • Male and female patients; older than 6 months of age; diagnosed with uncomplicated vivax malaria; with enzymatic activity between 10-60%

排除标准

  • Patients with severe malaria; hemoglobin levels below 9 g/dL; pregnant or breastfeeding females; children less than 6 months old; with severe enzymatic deficiency (enzymatic activity less than 10%); nephropathy; hepatopathy; under the use of potentially hemolytic drugs specified in the project; under the use of antimalarial drugs until two weeks before the study

研究者

发起方
Fundação de Medicina Tropical Heitor Vieira Dourado - FMTHVD

相似试验